SLC2A1 and glioblastoma: found that HSP90B1 is significantly upregulated in radioresistant GBM cell lines, and that HSP90B1 promotes the localization of GLUT1 on the plasma membrane, enhances glycolytic activity, and thereby enhances tumor growth and radioresistance in GBM cells.